Skip to content
Baker Capital StrategiesMARKETS. FILINGS. PERSPECTIVE.
Powered by THEMA

Baker Capital Strategies

Free Registration

Register for access to news, tools, alerts and reports.

THEMA Basic included at launch.

Use at least 8 characters.

Quarterly Report · 10-Q

Phreesia, Inc.

PHRNYSEEQUITYCurrent

Quarterly Report

Filed Dec 9, 2025Accepted Dec 9, 2025, 4:02 PM ESTCIK 1412408Accession 0001412408-25-000132
Share

Company context

Phreesia is a trusted leader in patient activation, giving healthcare providers, life sciences companies and other organizations tools to help patients take a more active role in their care. Founded in 2005, Phreesia enabled approximately 170 million patient visits in 2024 - 1 in 7 visits across the U.S. - scale that we believe allows us to make meaningful impact. Offering patient-driven digital solutions for intake, outreach, education and more, Phreesia enhances the patient experience, drives efficiency and improves healthcare outcomes.

Current securities

Recent company filings

  1. 4 filingSep 22, 2026
  2. 144 filingSep 21, 2026
  3. 4 filingSep 16, 2026
  4. 4 filingSep 16, 2026
  5. S-3ASR filingSep 3, 2026

Document unavailable

This filing is not currently available in the archive. Read it on SEC EDGAR ↗